Volume10, Issue0 (2024)

Volume

Table of Contents (111 articles)

Pneumonia promotes pulmonary metastasis of HCC after transplantation via VEGF regulated PI3K/AKT/Cas-9 signaling and angiogenesis

Runzhou Zhuang, ... Xiao Xu

Progression of liver disease and associated risk of hepatocellular carcinoma

Edoardo Poli, ... Eleonora De Martin

Racial, ethnic, and socioeconomic differences in hepatocellular carcinoma across the United States

Adrian Diaz, ... Timothy M. Pawlik

Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma

Giuseppe Guido Maria Scarlata

, ... Ludovico Abenavoli

Is the Mediterranean diet a good preventive measure for NASH?

Anna Caterina Procopio, ... Ludovico Abenavoli

Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease

Carmen Colaci, ... Ludovico Abenavoli

MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma

Peyda Korhan

, ... Neşe Atabey

Emerging data on immune checkpoint inhibitors in the neoadjuvant and adjuvant setting for patients with hepatocellular carcinoma

Samantha M. Ruff, ... Timothy M. Pawlik

Interpretation of Chinese expert consensus on the whole-course management of hepatocellular carcinoma (2023 edition)

Yang Yang, ... Qiu Li

Precise staging of advanced HCC promotes higher quality of personalized treatment management: Chinese experts consensus on precision diagnosis and management of advanced hepatocellular carcinoma (2023)

Aizier Ainiwaer, ... Yinying Lu

Mutation-based therapies for intrahepatic cholangiocarcinoma: new options on the horizon

Si-yuan Pan, ... Shao-Lai Zhou

The role of percutaneous hepatic perfusion (PHP) in the treatment of cholangiocarcinoma

Cornelia L. A. Dewald

, ... Frank K. Wacker

Crosstalk between cancer cell plasticity and immune microenvironment in cholangiocarcinoma

Mirko Minini

, ... Laura Fouassier

Associations between physical activity and risk of liver cancer: results from a population-based cohort study in Chinese women

Jing-Yu Tan, ... Yong-Bing Xiang

Role of temporary portosystemic surgical shunt during liver resection to prevent a post-resection small for size-like syndrome

Jacopo Lanari, ... Umberto Cillo

Introduction of the Chinese expert consensus on postoperative adjuvant therapy for hepatocellular carcinoma (2023 Edition)

Haibin Zhang

Lymphatic spread from left-sided intrahepatic cholangiocarcinoma: reconsiderations based on the lymphatic drainage from the liver

Masayuki Ohtsuka

, ... Shinichiro Nakada

Hepatic arterial infusion chemotherapy: a review with technical notes

Tommaso Stecca

, ... Marco Massani

Contemporary perspectives on laparoscopic liver resection for hepatocellular carcinoma: unravelling the potential and limitations

Nikhil Suresh, ... Abdul Rahman Hakeem

Transarterial intervention therapy combined with systemic therapy for HCC: a review of recent five-year articles

Chao Fu, ... Guangwen Cao

Hepatocellular carcinoma recurrence after liver transplantation: risk factors, targeted surveillance and management options

Filippo Pelizzaro

, ... Patrizia Burra

HCC in MASLD: radiological appearance, diagnosis and treatment

Marco Dioguardi Burgio

, ... Valérie Vilgrain

Detection of urine circulating tumor DNA using droplet digital PCR for predicting hepatocellular carcinoma recurrence

Xin Zhang

, ... Xiu-Tao Fu

Sex differences in hepatocellular carcinoma

James KH Ho, ... Kristie H Fan

Prognostic value of lymphocyte subset levels in hepatocellular carcinoma following conventionally fractionated vs. stereotactic body radiotherapy

Si-Tong Wang, ... Yuan Zhuang

Advancements in hepatocellular carcinoma diagnosis and treatment: liquid biopsy and surgery as precision treatment

Alessandro D. Mazzotta, ... Desirée Bonci

Reflections and perspectives on adjuvant treatment in the setting of resected hepatocellular carcinoma

Matteo Donadon

, ... Michela Anna Polidoro

Introduction to 2023 Chinese expert consensus on the whole-course management of hepatocellular carcinoma

Jie Li, ... Jinglin Xia

Oncologic outcomes and rates of hepatotoxicity following stereotactic body radiotherapy for hepatocellular carcinoma

Matthew Whitmill, ... Ted K. Yanagihara

Multidisciplinary assessment of tumor response after internal and external radiation therapy for hepatocellular carcinoma

Mishal Mendiratta-Lala, ... Dawn Owen

Achieving SVR in patients with hepatitis C-related HCC is associated with an improvement in overall survival: real word data

María Fernanda Guerra Veloz

, ... Kosh Agarwal

Chinese expert consensus on composite ablation system for the treatment of primary liver cancer (2023 edition)

Zhiqiang Meng

RNA-based therapies in hepatocellular carcinoma: state of the art and clinical perspectives

Le Xing, ... Ming Liu

Liver injury and recovery following radiation therapy for hepatocellular carcinoma: insights from functional liver imaging

Peter Zaki, ... Matthew J. Nyflot

Introduction of Chinese expert consensus on neoadjuvant therapy for primary liver cancer (2023 edition)

Jizhou Wang, ... Lianxin Liu

Shedding light on the role of LAG-3 in hepatocellular carcinoma: unraveling immunomodulatory pathways

Konstantinos Arvanitakis

, ... Georgios Germanidis

Glioma-associated oncogene (GLI)-specific decoy oligodeoxynucleotide induces apoptosis and attenuates proliferation, colony formation, and migration in liver cancer cells

Zahra Hajilou, ... Massoud Vosough

Multidisciplinary treatment of hepatocellular carcinoma in 2023: Italian treatment guidelines

Piera Federico

, ... Bruno Daniele

The role of immune checkpoint inhibitors and/or Yttrium-90 radioembolization in the management of hepatocellular carcinoma: challenges of treatment sequence

Samantha M. Ruff, ... Timothy M. Pawlik

Measures for response assessment in HCC treatment

Fereshteh Yazdanpanah, ... Stephen Hunt

MASLD: an emerging factor in the pathophysiology and clinical management of ICC

Zong-Long Li

, ... Zhao-Hui Tang

Evaluation of the outcomes of staging laparoscopy in intrahepatic cholangiocarcinoma patients undergoing surgical resection: a multicenter retrospective study in China

Delong Qin, ... Zhaohui Tang

Interpretation of the updates of the Chinese guidelines for the diagnosis and treatment of primary liver cancer (CNLC-2024 Edition)

Hao Su, ... Tao Peng

Advancing immunotherapy for intrahepatic cholangiocarcinoma: exploring the tumor immune microenvironment and innovative treatments

Pengcheng Wei, ... Zhao Li

Impact of gut microbiome on immunotherapy resistance in hepatocellular carcinoma: a review article

Aun R. Shah, ... Sandeep Mukherjee

Minimally invasive surgery approaches in major liver resection for hepatocellular carcinoma

Odysseas P. Chatzipanagiotou, ... Timothy M. Pawlik

Advances in radiomics applications for intrahepatic cholangiocarcinoma: a comprehensive review and future directions

Jia-Wei Xu, ... De-Cai Yu

Chemoprevention of hepatocellular carcinoma associated with metabolic dysfunction-associated steatotic liver disease: an updated review

Averie Dickinson, ... Kara Wegermann

Local and systemic thrombotic complications in cirrhotic patients with hepatocellular carcinoma

Elisa Zanatta, ... Marco Senzolo

Impact of occult hepatitis B virus infection and high-fat diet on hepatocellular carcinoma development

Kun Chen

, ... Chunfeng Qu

The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review

Maria Rosaria Paravati, ... Ludovico Abenavoli

Night shift-induced circadian disruption: links to initiation of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and risk of hepatic cancer

Anjali Singh

, ... Narsingh Verma

Advances in external beam radiation for hepatocellular carcinoma, stereotactic body radiation therapy (SBRT) and particle therapy

Lokesh Seth, ... Kevin L. Stephans

Radioembolization for hepatocellular carcinoma: updated strategies and evolving clinical applications

Jirapa Chansangrat, ... Sameer Gadani

Activator protein-1 in liver pathology: from precancerous diseases to hepatocellular carcinoma

Fernanda Villarruel-Melquiades

, ... Javier Camacho

Radiotherapy efficacy and prognostic factors in hepatocellular carcinoma patients with cardiophrenic angle or superior diaphragmatic lymph nodes metastasis

Ting Ye, ... Boheng Zhang

Detection of urine circulating tumor DNA using droplet digital PCR for predicting hepatocellular carcinoma recurrence

Xin Zhang

, ... Xiu-Tao Fu

Prognostic value of lymphocyte subset levels in hepatocellular carcinoma following conventionally fractionated vs. stereotactic body radiotherapy

Si-Tong Wang, ... Yuan Zhuang

Sex differences in hepatocellular carcinoma

James KH Ho, ... Kristie H Fan

Advances in external beam radiation for hepatocellular carcinoma, stereotactic body radiation therapy (SBRT) and particle therapy

Lokesh Seth, Kevin L. Stephans

Activator protein-1 in liver pathology: from precancerous diseases to hepatocellular carcinoma

Fernanda Villarruel-Melquiades

, ... Javier Camacho

Local and systemic thrombotic complications in cirrhotic patients with hepatocellular carcinoma

Elisa Zanatta, ... Marco Senzolo

Radioembolization for hepatocellular carcinoma: updated strategies and evolving clinical applications

Jirapa Chansangrat

, Sameer Gadani

Impact of gut microbiome on immunotherapy resistance in hepatocellular carcinoma: a review article

Aun R. Shah, Sandeep Mukherjee

Radiotherapy efficacy and prognostic factors in hepatocellular carcinoma patients with cardiophrenic angle or superior diaphragmatic lymph nodes metastasis

Ting Ye, ... Boheng Zhang

Night shift-induced circadian disruption: links to initiation of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and risk of hepatic cancer

Anjali Singh

, ... Narsingh Verma

Advances in radiomics applications for intrahepatic cholangiocarcinoma: a comprehensive review and future directions

Jia-Wei Xu, ... De-Cai Yu

Hepatocellular carcinoma recurrence after liver transplantation: risk factors, targeted surveillance and management options

Filippo Pelizzaro

, ... Patrizia Burra

The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review

Maria Rosaria Paravati

, ... Ludovico Abenavoli

Transarterial intervention therapy combined with systemic therapy for HCC: a review of recent five-year articles

Chao Fu, ... Guangwen Cao

MASLD: an emerging factor in the pathophysiology and clinical management of ICC

Zong-Long Li

, ... Zhao-Hui Tang

Evaluation of the outcomes of staging laparoscopy in intrahepatic cholangiocarcinoma patients undergoing surgical resection: a multicenter retrospective study in China

Delong Qin, ... Zhaohui Tang

Advancing immunotherapy for intrahepatic cholangiocarcinoma: exploring the tumor immune microenvironment and innovative treatments

Pengcheng Wei, Zhao Li

Impact of occult hepatitis B virus infection and high-fat diet on hepatocellular carcinoma development

Kun Chen

, Chunfeng Qu

Chemoprevention of hepatocellular carcinoma associated with metabolic dysfunction-associated steatotic liver disease: an updated review

Averie Dickinson, ... Kara Wegermann

Liver injury and recovery following radiation therapy for hepatocellular carcinoma: insights from functional liver imaging

Peter Zaki, ... Matthew J. Nyflot

Oncologic outcomes and rates of hepatotoxicity following stereotactic body radiotherapy for hepatocellular carcinoma

Matthew Whitmill, ... Ted K. Yanagihara

Minimally invasive surgery approaches in major liver resection for hepatocellular carcinoma

Odysseas P. Chatzipanagiotou, ... Timothy M. Pawlik

The role of immune checkpoint inhibitors and/or Yttrium-90 radioembolization in the management of hepatocellular carcinoma: challenges of treatment sequence

Samantha M. Ruff, Timothy M. Pawlik

Glioma-associated oncogene (GLI)-specific decoy oligodeoxynucleotide induces apoptosis and attenuates proliferation, colony formation, and migration in liver cancer cells

Zahra Hajilou, ... Massoud Vosough

Multidisciplinary assessment of tumor response after internal and external radiation therapy for hepatocellular carcinoma

Mishal Mendiratta-Lala, ... Dawn Owen

Interpretation of the updates of the Chinese guidelines for the diagnosis and treatment of primary liver cancer (CNLC-2024 Edition)

Hao Su, ... Tao Peng

Achieving SVR in patients with hepatitis C-related HCC is associated with an improvement in overall survival: real word data

María Fernanda Guerra Veloz

, ... Kosh Agarwal

Hepatic arterial infusion chemotherapy: a review with technical notes

Tommaso Stecca

, ... Marco Massani

Measures for response assessment in HCC treatment

Fereshteh Yazdanpanah, ... Stephen Hunt

Contemporary perspectives on laparoscopic liver resection for hepatocellular carcinoma: unravelling the potential and limitations

Nikhil Suresh, ... Abdul Rahman Hakeem

Pneumonia promotes pulmonary metastasis of HCC after transplantation via VEGF regulated PI3K/AKT/Cas-9 signaling and angiogenesis

Runzhou Zhuang, ... Xiao Xu

RNA-based therapies in hepatocellular carcinoma: state of the art and clinical perspectives

Le Xing, ... Ming Liu

Multidisciplinary treatment of hepatocellular carcinoma in 2023: Italian treatment guidelines

Piera Federico

, Bruno Daniele

MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma

Peyda Korhan

, ... Neşe Atabey

Emerging data on immune checkpoint inhibitors in the neoadjuvant and adjuvant setting for patients with hepatocellular carcinoma

Samantha M. Ruff, Timothy M. Pawlik

Shedding light on the role of LAG-3 in hepatocellular carcinoma: unraveling immunomodulatory pathways

Konstantinos Arvanitakis

, ... Georgios Germanidis

Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma

Giuseppe Guido Maria Scarlata

, ... Ludovico Abenavoli

Lymphatic spread from left-sided intrahepatic cholangiocarcinoma: reconsiderations based on the lymphatic drainage from the liver

Masayuki Ohtsuka

, ... Shinichiro Nakada

Chinese expert consensus on composite ablation system for the treatment of primary liver cancer (2023 edition)

Zhiqiang Meng

Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease

Carmen Colaci, ... Ludovico Abenavoli

Progression of liver disease and associated risk of hepatocellular carcinoma

Edoardo Poli, Eleonora De Martin

Reflections and perspectives on adjuvant treatment in the setting of resected hepatocellular carcinoma

Matteo Donadon

, ... Michela Anna Polidoro

Introduction to 2023 Chinese expert consensus on the whole-course management of hepatocellular carcinoma

Jie Li, ... Jinglin Xia

The role of percutaneous hepatic perfusion (PHP) in the treatment of cholangiocarcinoma

Cornelia L. A. Dewald

, ... Frank K. Wacker

Role of temporary portosystemic surgical shunt during liver resection to prevent a post-resection small for size-like syndrome

Jacopo Lanari, ... Umberto Cillo

Introduction of Chinese expert consensus on neoadjuvant therapy for primary liver cancer (2023 edition)

Jizhou Wang, Lianxin Liu

Is the Mediterranean diet a good preventive measure for NASH?

Anna Caterina Procopio, ... Ludovico Abenavoli

Advancements in hepatocellular carcinoma diagnosis and treatment: liquid biopsy and surgery as precision treatment

Alessandro D. Mazzotta, Desirée Bonci

Introduction of the Chinese expert consensus on postoperative adjuvant therapy for hepatocellular carcinoma (2023 Edition)

Haibin Zhang

Racial, ethnic, and socioeconomic differences in hepatocellular carcinoma across the United States

Adrian Diaz, ... Timothy M. Pawlik

Interpretation of Chinese expert consensus on the whole-course management of hepatocellular carcinoma (2023 edition)

Yang Yang, ... Qiu Li

Precise staging of advanced HCC promotes higher quality of personalized treatment management: Chinese experts consensus on precision diagnosis and management of advanced hepatocellular carcinoma (2023)

Aizier Ainiwaer, ... Yinying Lu

Mutation-based therapies for intrahepatic cholangiocarcinoma: new options on the horizon

Si-yuan Pan, ... Shao-Lai Zhou

Crosstalk between cancer cell plasticity and immune microenvironment in cholangiocarcinoma

Mirko Minini

, ... Laura Fouassier

Associations between physical activity and risk of liver cancer: results from a population-based cohort study in Chinese women

Jing-Yu Tan, ... Yong-Bing Xiang